Nine Malaysian hospitals to work with WHO for drug trials on COVID-19
By Akshay Kedari  Date: 2020-04-06

Nine Malaysian hospitals to work with WHO for drug trials on COVID-19

With the growing COVID-19 crisis, various initiatives are being taken worldwide where numerous organizations of various scale and are contributing as much as they can towards the efforts. The WHO, the biggest global authority responsible for international public health, is planning a solidarity trial to test various drugs that could help fight the coronavirus.

In a recent press release, the WHO, in collaboration with the Health Ministry of Malaysia, announced that the country has been selected to be a participant in the “Solidarity Trial”. Nine hospitals across Malaysia have been selected and would very soon initiate drug testing for coronavirus.   

Health Director-General, Datuk Dr. Noor Hisham Abdullah stated that the Health Ministry has expedited the process to conduct drug testing for the treatment of coronavirus patients. The trials would be conducted under the safety standards that are set by the National Pharmaceutical Regulatory Agency.

Dr. Noor further added that the participation of Malaysia in this global trial might help discover life-saving medicines to combat COVID-19 by evaluating their effectiveness and safety. Clinical Research Malaysia and Institute for Clinical Research of the Health Ministry of Malaysia would also help with the implementation of drug trials across the nation.

Queen Elizabeth Hospital, Sarawak General Hospital, Tengku Ampuan Afzan Hospital, Melaka Hospital, Kuala Lumpur Hospital, Sungai Buloh Hospital, Penang Hospital, Sultanah Bahiyah Hospital, and Tuanku Fauziah Hospital are the nine hospitals that have been selected from Malaysia to conduct trails of several drugs.       

Dr. Chow Ting Soo will lead the research and drug trials in Malaysia, and would also have access to a team of 16 Infectious Disease pharmacists and physicians working in their respective hospitals. Dr. Soo is an Infectious Disease Consultant in Penang Hospital.

The drug trials would primarily test the effectiveness of four different treatment protocols utilizing various combinations of five drugs which include Hydroxychloroquine, Chloroquine, Interferon beta, Lopinavir/Ritonavir, and Remdesivir.

Source credit: https://www.thestar.com.my/news/nation/2020/04/06/covid-19-nine-m039sian-hospitals-to-start-who-global-drug-trial

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Rivian secures USD 2.65 billion months before its first vehicle launch
Rivian secures USD 2.65 billion months before its first vehicle launch
By Akshay Kedari

Electric vehicle startup, Rivian, backed by Ford Motor Co. and Amazon.com Inc., has reportedly announced an investment round of USD 2.65 billion led by T. Rowe Price, months before its first vehicle launch. Sources with knowledge of the matter state...

BMW drivers can now unlock and start cars without using their iPhone
BMW drivers can now unlock and start cars without using their iPhone
By Akshay Kedari

German multinational automobile manufacturer, Bayerische Motoren Werke AG, commonly known as BMW, has reportedly unveiled an upgraded version of its mobile car key technology, called the Digital Key Plus. This product enables iPhone users to unlock t...

FMCG firms resort to marginal hike to cope with raw material inflation
FMCG firms resort to marginal hike to cope with raw material inflation
By Akshay Kedari

The recent inflation in raw materials has reportedly prompted players in the FMCG sector to take price hike measures for their products, in a bid to maintain the revenues. According to reliable sources, some FMCG companies, including Marico, have al...

boAt raises USD 100 million in funding from Warburg Pincus
boAt raises USD 100 million in funding from Warburg Pincus
By Akshay Kedari

Indian consumer electronics brand, boAt, has reportedly secured funding of USD 100 million from Warburg Pincus, a New-York-based private equity firm, at a USD 300 million valuation. The company will utilize these funds to expand its product portfoli...

Elevar Therapeutics and Inceptua partner to commercialize Apealea®
Elevar Therapeutics and Inceptua partner to commercialize Apealea®
By Akshay Kedari

According to reliable sources, U.S.-based fully integrated biopharmaceutical company, Elevar Therapeutics Inc., has signed an exclusive agreement with Inceptua Group for the commercialization and distribution of its non-cremophor based paclitaxel tre...